FDA approves AstraZeneca, Nektar constipation drug

(Reuters) - The U.S. Food and Drug Administration approved an oral therapy to treat opioid-induced constipation developed by Nektar Therapeutics and AstraZeneca Plc.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news